Jinghua Pharmaceutical Group Co., Ltd.
Industry Group: Pharmaceuticals
Country/Region: China
Identifier: SHE:002349
Jinghua Pharmaceutical Group Co Ltd is engaged in the pharmaceutical research, development, manufacturing, and trading for active pharmaceutical ingredients, pharmaceutical intermediates, western medicines and proprietary Chinese medicine preparations. The company is also involved in the field of bio-medicine. It sells its products in China and also exports it to international countries.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 844 out of 921
Universe
Global Universe 14484 out of 16216
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Zymeworks, Inc. |
29
Medium
|
478 out of 921 |
Oric Pharmaceuticals, Inc. |
31.9
High
|
612 out of 921 |
Icosavax, Inc. |
33.3
High
|
690 out of 921 |
Phibro Animal Health Corp. |
33.9
High
|
716 out of 921 |
Jinghua Pharmaceutical Group Co., Ltd. |
37.3
High
|
844 out of 921 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Jinghua Pharmaceutical Group Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Jinghua Pharmaceutical Group Co., Ltd.'s Management of ESG Material Risk is Weak